Cover Image

Diagnostic Accuracy of [<sup>68</sup>Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis

Several studies have examined the use of positron emission tomography (PET) using [<sup>68</sup>Ga]Ga-radiolabeled fibroblast-activation protein inhibitors (FAPi) across multiple subtypes of head and neck cancer (HNC). The purpose of the present study was to evaluate the diagnostic accur...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessio Rizzo (Author), Alberto Miceli (Author), Manuela Racca (Author), Matteo Bauckneht (Author), Silvia Morbelli (Author), Domenico Albano (Author), Francesco Dondi (Author), Francesco Bertagna (Author), Danilo Galizia (Author), Barbara Muoio (Author), Salvatore Annunziata (Author), Giorgio Treglia (Author)
Format:	Book
Published:	MDPI AG, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
by: Alessio Rizzo, et al.
Published: (2022)

Automated GMP Production and Preclinical Evaluation of [<sup>68</sup>Ga]Ga-TEoS-DAZA and [<sup>68</sup>Ga]Ga-TMoS-DAZA
by: Julia Greiser, et al.
Published: (2022)

[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023)

Automated Production of [<sup>68</sup>Ga]Ga-Desferrioxamine B on Two Different Synthesis Platforms
by: Martin Kraihammer, et al.
Published: (2024)

Automated Synthesis of [<sup>68</sup>Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
by: Elisabeth Plhak, et al.
Published: (2023)

Development and Preclinical Evaluation of [<sup>68</sup>Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression
by: Yong Huang, et al.
Published: (2023)

Synthesis and Evaluation of Novel <sup>68</sup>Ga-Labeled [D-Phe<sup>6</sup>,Leu<sup>13</sup>ψThz<sup>14</sup>]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography
by: Lei Wang, et al.
Published: (2024)

Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
by: Rahul Viswanathan, et al.
Published: (2024)

<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021)

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
by: Zarif Ashhar, et al.
Published: (2022)

Peptide-Based [<sup>68</sup>Ga]Ga Labeled PET Tracer for Tumor Imaging by Targeting Tumor-Associated Macrophages
by: Mingxing Huang, et al.
Published: (2022)

GMP-compliant production of [68Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor
by: Marc Pretze, et al.
Published: (2021)

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Lukas Greifenstein, et al.
Published: (2022)

[<sup>68</sup>Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [<sup>18</sup>F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma
by: Anton Amadeus Hörmann, et al.
Published: (2024)

Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68</sup>Ga-Labeled Radiopharmaceuticals
by: Rahel H. Wallimann, et al.
Published: (2024)

Competition ('Steal' Phenomenon) between [<sup>68</sup>Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue
by: Esmée C. A. van der Sar, et al.
Published: (2021)

Standardization of the [<sup>68</sup>Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer
by: Leonardo L. Fuscaldi, et al.
Published: (2021)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023)

Improved Radiolytic Stability of a <sup>68</sup>Ga-labelled Collagelin Analogue for the Imaging of Fibrosis
by: Irina Velikyan, et al.
Published: (2021)

Functionalization of <sup>68</sup>Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities
by: Thomas Wanek, et al.
Published: (2024)

Evaluation of [<sup>68</sup>Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections
by: Palesa C. Koatale, et al.
Published: (2024)

Automated GMP-Compliant Production of [<sup>68</sup>Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
by: Michael Wagner, et al.
Published: (2020)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

Synthesis of <sup>68</sup>Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
by: Barbara Gyuricza, et al.
Published: (2021)

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020)

<sup>68</sup>Ga-HBED-CC-WL-12 PET in Diagnosing and Differentiating Pancreatic Cancers in Murine Models
by: Qiying Xiang, et al.
Published: (2023)

<sup>68</sup>Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
by: Henri Baudhuin, et al.
Published: (2021)

<i>N</i>-Benzylethanolammonium Ionic Liquids and Molten Salts in the Synthesis of <sup>68</sup>Ga- and Al<sup>18</sup>F-Labeled Radiopharmaceuticals
by: Yulia A. Kondratenko, et al.
Published: (2023)

Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging
by: Jaykanth Amalachandran, et al.
Published: (2024)

Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of <sup>68</sup>Ga-, <sup>205/206</sup>Bi-, and <sup>177</sup>Lu-Labeled NAPamide-Based Radiopharmaceuticals
by: Dániel Szücs, et al.
Published: (2023)

Radiosynthesis Standardization and Preclinical Assessment of the [<sup>68</sup>Ga]Ga-DOTA-Ubiquicidin<sub>29-41</sub>: A Translational Study Targeting Differential Diagnosis of Infectious Processes
by: Ana Cláudia Camargo Miranda, et al.
Published: (2023)

Differences in Distribution and Detection Rate of the [<sup>68</sup>Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11-Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer
by: Falk Gühne, et al.
Published: (2021)

Imageological/Structural Study regarding the Improved Pharmacokinetics by <sup>68</sup>Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer
by: Huihui Zhang, et al.
Published: (2023)

Preclinical PET Imaging and Toxicity Study of a <sup>68</sup>Ga-Functionalized Polymeric Cardiac Blood Pool Agent
by: Katayoun Saatchi, et al.
Published: (2023)

Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [<sup>68</sup>Ga]Ga-PSMA-11
by: Vincent Nail, et al.
Published: (2022)

[<sup>68</sup>Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [<sup>18</sup>F]FDG PET and CT
by: Hao Ji, et al.
Published: (2024)

In Vivo Evaluation of <sup>68</sup>Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model
by: Jun Young Park, et al.
Published: (2024)